Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 9-28 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1,3,5-8,10-12,14-20 of U.S. Patent No. 12196377. Although the claims at issue are not identical, they are not patentably distinct from each other because the claims of the instant application are anticipated by those of the issued patent (see below).
Application 18/975687
U.S. Patent 12196377
9. A light emitting device that inactivates microorganisms, the light emitting device comprising: at least one light source configured to emit a first light comprising a first peak wavelength;
and a light converting layer disposed over the at least one light source, the light converting layer comprising: a first light converting material configured to convert only a first portion of the first light to at least a second light comprising a second peak wavelength different from the first peak wavelength; a second light converting material configured to convert only a second portion of the first light to at least a third light comprising a third peak wavelength different from the first peak wavelength and the second peak wavelength; wherein the first light converting material and the second light converting material are homogenously mixed together to form the light converting layer; and wherein at least the first light, the second light, and the third light mix to form a disinfecting white light comprising: a proportion of spectral energy measured within a range of 380 nanometers (nm) to 420 nm of at least 20%.
10. The light emitting device of claim 9, wherein the first light is a blue light.
11. The light emitting device of claim 9, wherein the first light comprises a first peak wavelength in a range of 380 nanometers (nm) to 420 nm.
12. The light emitting device of claim 11, further comprising a third light converting material within the light converting layer configured to convert only a third portion of the first light to at least a fourth light comprising a peak wavelength different from the first, the second, and the third peak wavelength, wherein the first light, the second light, the third light, and the fourth light mix to form a disinfecting white light.
13. The light emitting device of claim 9, further comprising a substrate, wherein the at least one light source is disposed on the substrate and wherein the light converting layer is disposed over the substrate and the at least one light source.
14. The light emitting device of claim 9, wherein the disinfecting white light further comprises a proportion of spectral energy measured within a range of 440 nm to 495 nm of 10% or less.
15. The light emitting device of claim 9, wherein an intensity in a range of 380 nm to 420 nm is at least 0.01 milliwatts per centimeter squared (mW/cm2).
16. The light emitting device of claim 9, further comprising a substrate, wherein the at least one light source is disposed over a surface of the substrate, and wherein the light converting layer is disposed over the at least one light source and the substrate.
17. The light emitting device of claim 9, wherein the third light comprises one of: a red light within a wavelength range of 620 nm to 750 nm; or a green light within a wavelength range of 495 nm to 570 nm.
18. The light emitting device of claim 12, wherein the second light, the third light or the fourth light comprises one of: a blue light within a wavelength range of 440 nm to 495 nm; or a red light within a wavelength range of 620 nm to 750 nm; or a green light within a wavelength range of 495 nm to 570 nm.
19. A light emitting device that inactivates microorganisms, the light emitting device comprising: a first light source configured to emit a first light comprising a first peak wavelength; and a second light source configured to emit a same first light comprising a same first peak wavelength;
a light converting layer disposed over the first light source and the second light source, the light converting layer comprising: a first light converting material configured to convert only a first portion of the first light to at least a second light comprising a second peak wavelength different from the first peak wavelength;
a second light converting material
configured to convert only a first portion of the first light to at least a third light comprising a third peak wavelength different from the first peak wavelength and the second peak wavelength; wherein at least the first light, the second light, and the third light mix to form a disinfecting white light comprising: a proportion of spectral energy measured within a range of 380 nanometers (nm) to 420 nm of at least 20%.
20. The light emitting device of claim 19, wherein the first light is a blue light.
21. The light emitting device of claim 19, wherein the first light comprises a first peak wavelength in a range of 380 nanometers (nm) to 420 nm.
22. The light emitting device of claim 21, further comprising a third light converting material within the light converting layer configured to convert only a third portion of the first light to at least a fourth light comprising a peak wavelength different from the first, the second, and the third peak wavelength, wherein the first light, the second light, the third light, and the fourth light mix to form a disinfecting white light.
23. The light emitting device of claim 19, further comprising a substrate, wherein the first light source and second light source are disposed onto the substrate and wherein the light converting layer is disposed over the substrate, the first light source, and the second light source.
24. The light emitting device of claim 19, wherein the disinfecting white light further comprises a proportion of spectral energy measured within a range of 440 nm to 495 nm of 10% or less.
25. The light emitting device of claim 19, wherein an intensity in a range of 380 nm to 420 nm is at least 0.01 milliwatts per centimeter squared (mW/cm2).
26. The light emitting device of claim 19, wherein the disinfecting white light comprises a proportion of spectral energy measured within a range of 380 nanometers (nm) to 420 nm of at least 30%.
27. The light emitting device of claim 19, wherein the second or the third light comprises one of: a red light within a wavelength range of 620 nm to 750 nm; or a green light within a wavelength range of 495 nm to 570 nm.
28. The light emitting device of claim 22, wherein the second light, the third light or the fourth light comprises one of: a blue light within a wavelength range of 440 nm to 495 nm; or a red light within a wavelength range of 620 nm to 750 nm; or a green light within a wavelength range of 495 nm to 570 nm.
1. A light emitting device that inactivate microorganisms, the light emitting device comprising: at least one light emitter configured to emit a first light comprising a first peak wavelength wherein the first light is a blue light; and a light converting layer disposed over the at least one light emitter, the light converting layer comprising: a first light-converting material configured to convert only a first portion of the first light to at least a second light comprising a second peak wavelength different from the first peak wavelength; a second light-converting material configured to convert only a second portion of the first light to at least a third light comprising a third peak wavelength different from the first peak wavelength and the second peak wavelength; wherein the first light-converting material and the second light-converting material are homogenously mixed together to form the light converting layer; and wherein at least the first light, the second light, and the third light mix to form a disinfecting white light comprising: a proportion of spectral energy measured within a range of 380 nanometers (nm) to 420 nm of at least 20%.
3. The light emitting device of claim 1, further comprising a third light converting material within the light converting layer configured to convert only a first portion of the first light to at least a fourth light comprising a peak wavelength different from the first, the second, and the third peak wavelength, wherein the first light, the second light, the third light, and the fourth light mix to form a disinfecting white light.
5. The light emitting device of claim 1, further comprising a substrate, wherein the at least one light emitter is disposed onto the substrate.
6. The light emitting device of claim 5, where in the light converting layer is disposed over the substrate and the at least one light emitter.
7. The light emitting device of claim 1, wherein the disinfecting white light further comprises a proportion of spectral energy measured within a range of 440 nm to 495 nm of 10% or less.
8. The light emitting device of claim 1, wherein an intensity in the 380 nm to 420 nm range is at least 0.01 milliwatts per centimeter squared (mW/cm2).
5. The light emitting device of claim 1, further comprising a substrate, wherein the at least one light emitter is disposed onto the substrate.
6. The light emitting device of claim 5, where in the light converting layer is disposed over the substrate and the at least one light emitter.
10. The light emitting device of claim 1, wherein the third light comprises one of: a red light within a wavelength range of 620 nm to 750 nm; or a green light within a wavelength range of 495 nm to 570 nm.
10. The light emitting device of claim 1, wherein the third light comprises one of: a red light within a wavelength range of 620 nm to 750 nm; or a green light within a wavelength range of 495 nm to 570 nm
11. A light emitting device that inactivates microorganisms, the light emitting device comprising: a first light emitter configured to emit a first light comprising a first peak wavelength; and a second light emitter configured to emit a same first light comprising a same first peak wavelength; wherein the first light is a blue light;
a first light converting layer disposed over the first light emitter, the first light converting layer comprising: a first light converting material configured to convert only a first portion of the first light to at least a second light comprising a second peak wavelength different from the first peak wavelength;
a second light converting layer disposed over the second light emitter, the second light converting layer comprising: a third light converting material configured to convert only a first portion of the first light to at least a third light comprising a third peak wavelength different from the first peak wavelength and the second peak wavelength; wherein at least the first light, the second light, and the third light mix to form a disinfecting white light comprising: a proportion of spectral energy measured within a range of 380 nanometers (nm) to 420 nm of at least 20%.
12. The light emitting device of claim 11, wherein the second light converting layer further comprises a third light converting material configured to convert only a first portion of the first light to at least a fourth light comprising a peak wavelength different from the first, the second, and the third peak wavelength, wherein the first light, the second light, the third light, and the fourth light mix to form a disinfecting white light.
14. The light emitting device of claim 11, further comprising a substrate, wherein the first light emitter and second light emitter are disposed onto the substrate.
15. The light emitting device of claim 14, wherein the first light converting layer is disposed over at least a portion of the substrate and the first light emitter; and the second light converting layer is disposed over at least a portion of the substrate and the second light emitter.
16. The light emitting device of claim 11, wherein the disinfecting white light further comprises a proportion of spectral energy measured within a range of 440 nm to 495 nm of 10% or less.
17. The light emitting device of claim 11, wherein an intensity in the 380 nm to 420 nm range is at least 0.01 milliwatts per centimeter squared (mW/cm2).
18. The light emitting device of claim 11, wherein the disinfecting white light comprises a proportion of spectral energy measured within a range of 380 nanometers (nm) to 420 nm of at least 30%.
19. The light emitting device of claim 11, wherein the third light comprises one of: a red light within a wavelength range of 620 nm to 750 nm; or a green light within a wavelength range of 495 nm to 570 nm.
20. The light emitting device of claim 12, wherein the fourth light comprises one of: a red light within a wavelength range of 620 nm to 750 nm; or a green light within a wavelength range of 495 nm to 570 nm.
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. USPN 2025/0052402.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Christopher Raabe whose telephone number is (571)272-8434. The examiner can normally be reached M-F 0530-1430.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James R Greece can be reached at (571)272-3711. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/CHRISTOPHER M RAABE/Primary Examiner, Art Unit 2875
Prosecution Insights